Tumor grade as a prognostic factor in primary breast cancer

1984, Editorial, 2, 1205 Bonadonna, 1988, The contribution of medicine to the primary treatment of breast cancer, Cancer Res, 48, 2314 Bonadonna, 1986, Breast Cancer, 13, 383 Bonadonna, 1987, Breast Cancer, 14, 1 Fisher, 1975, Ten year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy, Surg Gynecol Obstet, 140, 528 Valagussa, 1978, Patterns of relapse and survival following radical mastectomy, 41, 1170 Fisher, 1975, l-Phenylalanine mustard (l-PAM) in the management of primary breast cancer, N Engl J Med, 292, 117, 10.1056/NEJM197501162920301 Bonadonna, 1976, Combination chemotherapy as an adjuvant in operable breast cancer, N Engl J Med, 294, 405, 10.1056/NEJM197602192940801 1986, 1, 1 Von Hanseman, 1882, Über die Anaplasie des Geschwulstzellen und die asymetrische mitose, Virchows Arch Pathol Anat, 436 Gricouroff, 1948, Du pronostic histologique dans le cancer du sein, Bull Ass Franc Cancer, 35, 275 Scarff, 1938, Prognosis in carcinoma of the breast, Lancet, 235, 582, 10.1016/S0140-6736(00)82767-1 Bloom, 1957, Histological grading and prognosis in breast cancer, 11, 359 Black, 1957, Nuclear structure in cancer tissues, Surg Gynecol Obstet, 105, 97 Van de Velde, 1986, Prognosis in node negative breast cancer, Breast Cancer Res Treat, 8, 189, 10.1007/BF01807331 Hamlin, 1968, Possible host resistance in carcinoma of the breast: a histological study, Br J Cancer, 22, 383, 10.1038/bjc.1968.47 Tremblay, 1974, Elastosis in tubular carcinoma of the breast, Arch Pathol, 98, 302 Fisher, 1980, Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol B04). VI. Discriminants for five-year treatment failure, Cancer, 46, 908, 10.1002/1097-0142(19800815)46:4+<908::AID-CNCR2820461310>3.0.CO;2-5 Fisher, 1983, Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer, J Clin Oncol, 1, 227, 10.1200/JCO.1983.1.4.227 Fisher, 1987, Long term results from NSABP trials of adjuvant therapy for breast cancer, 5, 283 Lash, 1986, Partial mastectomy: pathologic findings and prognosis, Hum Pathol, 17, 813, 10.1016/S0046-8177(86)80202-7 Gilchrist, 1985, Interobserver reproducibility of histopathological features in stage II breast cancer, Breast Cancer Res Treat, 5, 3, 10.1007/BF01807642 Fisher, 1985, Comment on ‘Interobserver reproducibility of histopathological features in stage II breast cancer’, by KW Gilchrist et al., Breast Cancer Res Treat, 5, 11, 10.1007/BF01807643 Fisher, 1984, Pathologic findings from the National Surgical Adjuvant Project for breast cancers (Protocol N. 4). X. Discriminants for tenth year treatment failure, Cancer, 53, 712, 10.1002/1097-0142(19840201)53:3+<712::AID-CNCR2820531320>3.0.CO;2-I Fisher, 1986, Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer, Breast Cancer Res Treat, 7, 147, 10.1007/BF01806245 Rosen, 1986, Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy?, Cancer, 57, 1415, 10.1002/1097-0142(19860401)57:7<1415::AID-CNCR2820570729>3.0.CO;2-K Davis, 1986, Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis, Cancer, 58, 2662, 10.1002/1097-0142(19861215)58:12<2662::AID-CNCR2820581219>3.0.CO;2-Y Contesso, 1987, The importance of histologic grade in long-term prognosis of breast cancer, 5, 1378 WHO, 1982, Histologic typing of breast tumors, 78, 806 Russo, 1987, Predictors of recurrence and survival of patients with breast cancer, Am J Clin Pathol, 88, 123, 10.1093/ajcp/88.2.123 Knight, 1977, Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer, Cancer Res, 37, 4669 Rich, 1978, Prognostic value of estrogen receptor determinations in patients with breast cancer, Cancer Res, 38, 4296 Allegra, 1979, Association between steroid hormone receptor status and disease-free interval in breast cancer, Cancer Treat Rep, 63, 1271 Valagussa, 1984, Are estrogen receptors alone a reliable prognostic factor in node-negative breast cancer?, 4, 407 Crowe, 1982, Estrogen receptor status as a prognostic indication for stage I breast cancer patients, Breast Cancer Res Treat, 2, 171, 10.1007/BF01806453 Osborne, 1985, Heterogeneity in hormone receptor status in primary and metastatic breast cancer, Sem Oncol, 12, 317 Clark, 1983, Progesterone receptor as a prognostic factor in stage II breast cancer, N Engl J Med, 309, 1343, 10.1056/NEJM198312013092240 McGuire, 1987, Prognostic factors for recurrence and survival in human breast cancer, Breast Cancer Res Treat, 10, 5, 10.1007/BF01806129 Brincker, 1987, Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer, J Clin Oncol, 5, 1771, 10.1200/JCO.1987.5.11.1771 Tubiana, 1984, The long-term prognostic significance of the thymidine labeling index in breast cancer, Int J Cancer, 33, 441, 10.1002/ijc.2910330404 Silvestrini, 1986, Prognostic implication of labeling index versus estrogen receptors and tumor size in node negative breast cancer, Breast Cancer Res Treat, 7, 161, 10.1007/BF01806246 Meyer, 1986, Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma, NCI Monogr, 1, 25 Merkel, 1987, Flow cytometry, cellular DNA content and prognosis in human malignancy, J Clin Oncol, 5, 1690, 10.1200/JCO.1987.5.10.1690 Dressler, 1988, DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens, Cancer, 61, 420, 10.1002/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO;2-0 Lellé, 1987, The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma, Cancer, 59, 83, 10.1002/1097-0142(19870101)59:1<83::AID-CNCR2820590119>3.0.CO;2-I Mansi, 1987, Micrometastases in bone marrow in patients with breast cancer: evolution as an early predictor of bone metastases, Br Med J, 295, 1093, 10.1136/bmj.295.6606.1093 Mareel, 1966, Are oncogenes involved in invasion and metastasis?, Anticancer Res, 6, 419 McGuire, 1987, Oncogenes in clinical cancer, 10, 217 Fromowitz, 1987, Ras p21 expression in the progression of breast cancer, Hum Pathol, 18, 1268, 10.1016/S0046-8177(87)80412-4 Slamon, 1987, Amplification of the HER-2/neu oncogene correlates with relapse and survival in human breast cancer, Science, 235, 177, 10.1126/science.3798106 Tandon, 1988, Over-expression of the HER-2/neu oncogene predicts relapse and survival in stage II human breast cancers, 7 Cline, 1987, Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease, J Clin Oncol, 5, 999, 10.1200/JCO.1987.5.7.999 Fisher, 1983, Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation, Cancer, 51, 181, 10.1002/1097-0142(19830115)51:2<181::AID-CNCR2820510202>3.0.CO;2-A Berger, 1987, Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features in primary breast cancer, Hum Pathol, 18, 1263, 10.1016/S0046-8177(87)80411-2